EUVIMEDObjevte EUVIMED
Randomisierte kontrollierte Studie

Clinical trial: Efficacy of a Low FODMAP Diet in Paediatric Irritable Bowel Syndrome—A Randomised Crossover Trial With Exploratory Metabolomic Analysis

Fernanda Cristofori, Giuseppe Celano, Vanessa Nadia Dargenio, Carmen Aurora Apa iD, Monica Amendolara, Maria Stella, Stefania Castellaneta, Michele Barone iD, Mirco Vacca iD, Maria De Angelis, Ruggiero Francavilla

Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (12) · 1592-1604

DOI: 10.1111/apt.70718 ↗

At a glance

Randomisierte kontrollierte Studie in Alimentary Pharmacology & Therapeutics, published online on 2026-05-13. Written by Fernanda Cristofori and 10 co-authors. Institution: Interdisciplinary Department of Medicine, Paediatric Section, Children's Hospital' Giovanni XXIII', University of Bari Aldo Moro, Bari, Italy. Major MEDLINE topics: Irritable Bowel Syndrome, FODMAP Diet. Cited 2 times so far (Crossref); 39 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Evidence supporting the low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet in paediatric irritable bowel syndrome (IBS) remains limited. Mechanisms underlying inter‐individual variability in dietary response in children are poorly understood.

Aim

To compare the clinical efficacy of a low FODMAP diet (LFD) versus a dietitian‐guided habitual diet (HD; standard FODMAP intake) in children with IBS and to identify faecal and urinary metabolomic signatures associated with treatment response.

Methods

Single‐centre, randomised assessor‐blinded crossover trial. Children with Rome IV‐defined IBS underwent a 2‐week run‐in, followed by 14 days of LFD or dietitian‐guided HD, a 2‐week washout, and crossover to the alternate diet. The primary outcome was treatment success (≥ 50% reduction in abdominal pain; period‐specific baseline VAS). Secondary outcomes included IBS Severity Scoring System (IBS‐SSS), stool pattern, and metabolomic profiling.

Results

Sixty‐six children (mean age 10.2 years) completed the trial. Treatment success was achieved in 57.6% during LFD versus 30.3% during HD ( p = 0.024), with the greatest benefit observed in children with severe baseline pain (VAS > 5). LFD was associated with significant reductions in IBS‐SSS scores and bloating. Targeted SCFA analyses showed lower faecal acetic acid during LFD than during HD, while exploratory faecal and urinary volatilome analyses identified candidate features associated with response categories.

Conclusion

In this randomised crossover trial, a LFD improved abdominal pain and symptom severity in children with IBS, with the greatest benefit in those with severe baseline pain. Exploratory faecal and urinary metabolomic analyses identified candidate features associated with non‐response, warranting further validation. Trial Registration ClinicalTrials.gov identifier: NCT06618677

Subjects

MeSH terms (MEDLINE)

Irritable Bowel SyndromeFODMAP DietHumansCross-Over StudiesFemaleTreatment OutcomeChildMetabolomicsFecesMaleAdolescentAbdominal Pain

Authors and institutions

  • Interdisciplinary Department of Medicine, Paediatric Section, Children's Hospital' Giovanni XXIII', University of Bari Aldo Moro, Bari, Italy.
  • Department of Soil, Plant and Food Sciences, University of Bari Aldo Moro, Bari, Italy.
  • Ecclesiastical Entity General Regional Hospital Francesco Miulli, Acquaviva Delle Fonti, Italy.
  • Endocrinology-Diabetology Unit, Cittadella della Salute (Health Centre), Lecce Local Health Authority, Lecce, Italy.
  • Department of Precision and Regenerative Medicine and Jonian Area, University of Bari Aldo Moro, Bari, Italy.

ORCID profiles: Carmen Aurora Apa, Michele Barone, Mirco Vacca

Cite

APA

Cristofori, F., Celano, G., Dargenio, V. N., Apa, C. A., Amendolara, M., Stella, M., Castellaneta, S., Barone, M., Vacca, M., De Angelis, M., & Francavilla, R. (2026). Clinical trial: Efficacy of a Low FODMAP Diet in Paediatric Irritable Bowel Syndrome—A Randomised Crossover Trial With Exploratory Metabolomic Analysis. Alimentary Pharmacology & Therapeutics, 63(12), 1592-1604. https://doi.org/10.1111/apt.70718

Vancouver

Cristofori F, Celano G, Dargenio VN, Apa CA, Amendolara M, Stella M, et al. Clinical trial: Efficacy of a Low FODMAP Diet in Paediatric Irritable Bowel Syndrome—A Randomised Crossover Trial With Exploratory Metabolomic Analysis. Alimentary Pharmacology & Therapeutics. 2026;63(12):1592-1604. doi:10.1111/apt.70718

BibTeX
@article{Cristofori2026,
  author = {Cristofori, Fernanda and Celano, Giuseppe and Dargenio, Vanessa Nadia and Apa, Carmen Aurora and Amendolara, Monica and Stella, Maria and Castellaneta, Stefania and Barone, Michele and Vacca, Mirco and De Angelis, Maria and Francavilla, Ruggiero},
  title = {Clinical trial: Efficacy of a Low FODMAP Diet in Paediatric Irritable Bowel Syndrome—A Randomised Crossover Trial With Exploratory Metabolomic Analysis},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {63},
  number = {12},
  pages = {1592--1604},
  doi = {10.1111/apt.70718}
}
Start for free →